Meifang Wang
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 5%
- Long-Term Effects of COVID-19
Papers in
-
- Pleural and Pulmonary Diseases 4
- Ferroptosis and cancer prognosis 4
- Lung Cancer Diagnosis and Treatment 4
- Photodynamic Therapy Research Studies 3
- Medical Imaging and Pathology Studies 3
- Genetics 5
- Co-authors
- Yan Deng (1 shared paper)Kui Liu (1 shared paper)Huiguo Liu (1 shared paper)Ying-Nan Wang (1 shared paper)Wei Lie Xiao (1 shared paper)Wei Yong Liu (1 shared paper)Elaine Lai‐Han Leung (11 shared papers)Xin Qian (10 shared papers)
- Journals
- Journal of Cellular Physiology (5 papers)Medicine (3 papers)Frontiers in Medicine (3 papers)Photodiagnosis and Photodynamic Therapy (2 papers)Clinical Rheumatology (2 papers)
- Partner nations
- ChinaMacaoUnited States
In The Last Decade
Meifang Wang
73 papers receiving 2.5k citations
Meifang Wang's Hit Papers
Peers
Comparison fields: 5 of 136
- Infectious Diseases 812
- Neurology 412
- Pulmonary and Respiratory Medicine 369
- Cancer Research 149
- Toxicology 36
Countries citing papers authored by Meifang Wang
This map shows the geographic impact of Meifang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meifang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meifang Wang more than expected).
Fields of papers citing papers by Meifang Wang
This network shows the impact of papers produced by Meifang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meifang Wang. The network helps show where Meifang Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Meifang Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 82 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province Hit paper breakdown → | 2020 | 1083 |
| 2 | 2020 | 181 | |
| 3 | 2016 | 103 | |
| 4 | 2005 | 99 | |
| 5 | 2020 | 96 | |
| 6 | 2023 | 64 | |
| 7 | 2019 | 60 | |
| 8 | 2019 | 59 | |
| 9 | 2022 | 50 | |
| 10 | 2003 | 49 | |
| 11 | 2020 | 45 | |
| 12 | 2021 | 42 | |
| 13 | 2020 | 42 | |
| 14 | 2021 | 29 | |
| 15 | 2000 | 27 | |
| 16 | 2004 | 27 | |
| 17 | 2023 | 26 | |
| 18 | 2020 | 24 | |
| 19 | 2019 | 23 | |
| 20 | 2018 | 22 |
About Meifang Wang
Meifang Wang is a scholar working on Pulmonary and Respiratory Medicine, Genetics, Molecular Biology, Epidemiology and Infectious Diseases, having authored 82 papers that have together received 2.5k indexed citations. Recurring topics across this work include Fungal Infections and Studies (4 papers), Pleural and Pulmonary Diseases (4 papers), Ferroptosis and cancer prognosis (4 papers), Lung Cancer Diagnosis and Treatment (4 papers), Photodynamic Therapy Research Studies (3 papers), RNA modifications and cancer (3 papers), Medical Imaging and Pathology Studies (3 papers) and Antifungal resistance and susceptibility (3 papers). The work is most often cited by research in Infectious Diseases (812 citations), Neurology (412 citations), Pulmonary and Respiratory Medicine (369 citations), Cancer Research (149 citations) and Toxicology (36 citations). Meifang Wang has collaborated with scholars based in China, Macao and United States. Frequent co-authors include Yan Deng, Kui Liu, Huiguo Liu, Ying-Nan Wang, Wei Lie Xiao, Wei Yong Liu, Elaine Lai‐Han Leung, Xin Qian, Brian Irving Carr and Xing‐Xing Fan. Their work appears in journals such as Journal of Cellular Physiology, Medicine, Frontiers in Medicine, Photodiagnosis and Photodynamic Therapy and Clinical Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.